BrainAurora Medical Technology – HK$583 Million IPO

Hong Kong – January 8, 2025 – Cooley advised the sponsors and underwriters of BrainAurora Medical Technology in connection with its initial public offering (IPO) and listing on the Hong Kong Stock Exchange. The gross proceeds of the offering were approximately HK$583 million. The deal is the first IPO on the Hong Kong market in 2025.

BrainAurora is a seasoned player in China’s cognitive impairment digital therapeutics (DTx) market. It is the first company in China to develop a medical-grade DTx product for cognitive impairment, combining brain science with advanced artificial intelligence technologies.

BrainAurora’s shares were listed on the Hong Kong Stock Exchange on January 8, 2025, under the stock code 6681. China International Capital Corporation and SPDB International acted as the joint sponsors.

Partners Michael Yu and Yiming Liu led the Cooley team that advised the sponsors and underwriters.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.